Decision Guide · Updated May 2026
Naltrexone (oral) vs Vivitrol (XR-naltrexone injection)

Naltrexone (oral) vs Vivitrol (injectable)

Compare Naltrexone (oral) and Vivitrol (XR-naltrexone injection) across 12 decision points — cost, evidence, named criteria for choosing each option.

Last reviewed May 12, 2026 SAMHSA & NIDA sourced 12 data points 10 FAQ 8 sources
Talk to a licensed clinical advisor
  • Free & confidential
  • 24/7 availability
  • Insurance verified in 5 min
  • HIPAA-compliant
  • No pressure, just answers
Quick Verdict · ~30 sec read
Reviewed by RehabHive Editorial Team · Last updated May 12, 2026
Naltrexone (oral) and Vivitrol (extended-release injectable naltrexone) contain the same medication — what differs is delivery and adherence. Oral naltrexone is daily 50mg tablets; Vivitrol is a monthly 380mg intramuscular injection. Oral is cheap but adherence-dependent; Vivitrol guarantees 30 days of medication but costs $1,500+/month uninsured. Both require 7-10 days of complete opioid abstinence before starting (the major access barrier).
SAMHSA & NIDA sourced Peer-reviewed citations View sources
Save / Send
Email

Side-by-side comparison (12 decision points)

Factor Naltrexone (oral) Vivitrol (XR-naltrexone injection)
Pharmacology Mu-opioid receptor antagonist (oral) Same antagonist, extended-release injection
Dosing schedule Daily 50mg tablet Monthly 380mg IM injection
Adherence model Self-administered daily Clinician-administered monthly
FDA approval 1984 (OUD), 1995 (alcohol) 2010 (OUD + alcohol)
Pre-induction opioid abstinence 7-10 days required 7-10 days required
Cost (uninsured) $30-$80/month (generic) $1,500-$1,800/dose
Insurance coverage Tier 1-2 pharmacy benefit Tier 3-4 medical benefit (clinic-administered)
Discontinuation flexibility Stop anytime (no medication in system after 1-2 days) Effects continue 30 days after last dose
Real-world adherence Poor (under 40% at 6 months) Better (under 60% at 6 months)
Effective for alcohol use disorder Yes (FDA-approved) Yes (FDA-approved)
Liver monitoring required Yes (hepatotoxicity warning) Yes (hepatotoxicity warning)
Patient assistance programs Limited (generic — already cheap) Alkermes program (manufacturer)

Pros and cons

Naltrexone (oral)

Pros

  • Cheap — $30-$80/month uninsured
  • Easy to discontinue if side effects or pregnancy occurs
  • Stop anytime — out of system within 1-2 days
  • Wide pharmacy access — any retail pharmacy
  • Tier 1-2 insurance coverage with low copay
  • No clinic appointment burden

Cons

  • Adherence is poor — daily pill-taking required
  • Real-world 6-month retention under 40%
  • Easy to skip doses without consequence (until use occurs)
  • No "safety net" if motivation wavers — pill skipped = no protection
  • Patient must own daily commitment — no external structure

Vivitrol (XR-naltrexone injection)

Pros

  • Monthly injection guarantees 30 days of medication
  • Better real-world retention than oral naltrexone (~60% at 6 months)
  • No daily decision burden
  • Clinical visit + accountability built in
  • Excellent for court-ordered or monitored treatment
  • Strong evidence base in adolescent and young-adult populations

Cons

  • $1,500-$1,800 per dose uninsured (steep cost)
  • Injection site reactions in 5-10% of patients
  • Once injected, can't reverse if side effects occur — must wait 30 days
  • Requires clinical administration — can't self-inject
  • Same 7-10 day pre-induction abstinence barrier as oral
  • Some Medicaid programs require step therapy (try oral first)

When to choose each option

Named decision criteria for matching your specific situation to the right option.

When to choose Naltrexone (oral)

Cost-constrained situations

Oral naltrexone is the right choice when cost is a primary constraint. Generic oral naltrexone costs $30-$80/month uninsured versus $1,500-$1,800 for monthly Vivitrol — a 20-25x difference. For people without insurance or with high-deductible plans, this matters significantly. Some state Medicaid programs require step therapy (trying oral first) before approving Vivitrol.

Highly motivated for daily adherence

Oral naltrexone works well for people who are highly motivated for daily adherence — typically those with strong support systems, prior recovery experience, or stable mental health. Adherence is the central challenge: real-world 6-month retention for oral naltrexone is under 40% in most studies. If you're confident you'll take the pill daily, oral is appropriate.

Need for discontinuation flexibility

If discontinuation flexibility matters — for example, you might become pregnant, you have variable liver function requiring close monitoring, or you're uncertain about long-term commitment — oral naltrexone clears the system within 1-2 days. With Vivitrol, you're committed to 30 days of medication once injected. For people with anxiety about reversibility, oral provides peace of mind.

Full Naltrexone (oral) details →

When to choose Vivitrol (XR-naltrexone injection)

Daily adherence challenge

Vivitrol is preferred when daily adherence is a known challenge. If you've relapsed on oral naltrexone, missed doses leading to use, or simply find daily pill-taking unsustainable, the monthly injection model eliminates that variable. The medication is in your body for 30 days regardless of motivation fluctuations.

Early recovery structure

For people in early recovery (first 6-12 months) who benefit from external structure, the monthly clinical appointment for Vivitrol injection provides accountability + brief clinical contact. This is similar in spirit to OTP methadone clinic visits — the routine itself supports recovery.

Court-ordered or monitored treatment

If treatment is court-ordered, mandated by employer, or monitored by a probation officer, Vivitrol provides easy verification (monthly clinic visit documented). Oral naltrexone is impossible to verify outside drug testing. For high-stakes monitored situations, Vivitrol is structurally simpler.

Adolescent and young-adult populations

Vivitrol has stronger evidence base in adolescent and young-adult populations (under 25), where prefrontal cortex development affects daily decision-making. The monthly injection bypasses daily impulsivity — appropriate for college students, young adults transitioning to independence, or anyone whose executive function makes daily adherence harder.

Full Vivitrol (XR-naltrexone injection) details →

Cost & financial impact

Pricing ranges with cited sources (SAMHSA TIP, MEPS, AHRQ, KFF).

Pharmacy benefit costs (oral)

  • Medicaid generic naltrexone: $0-$5 copay (universally covered)
  • Private insurance generic: $5-$20/month copay typical
  • Uninsured generic via GoodRx: $30-$80/month (50mg × 30 days)
  • Brand Revia: $150-$250/month (rarely prescribed — generic equivalent)

Medical benefit costs (Vivitrol injection)

  • Medicaid: $0-$50 copay per dose in most states (federally covered for OUD)
  • Private insurance: $50-$300 copay per dose (varies by plan)
  • Medicare Part B: 20% coinsurance after deductible ($300+ per dose typical)
  • Uninsured: $1,500-$1,800 per dose; Alkermes patient assistance program available

Insurance coverage realities

Both medications are covered by Medicaid in all 50 states and by private insurance under MHPAEA federal parity. Some commercial plans require step therapy — patient must try oral naltrexone first and fail before Vivitrol is approved. This is controversial but legally permitted under most plans. If denied, appeal under MHPAEA parity provisions.

Alkermes (Vivitrol manufacturer) offers VivitrolConnect — patient assistance for uninsured + copay assistance for insured. State opioid response (SOR) grants fund Vivitrol access for uninsured in most states.

Our verdict

Choose Naltrexone (oral) if...

cost is a primary constraint, you're highly motivated for daily adherence, you don't want monthly injections, or you need flexibility to adjust dose quickly

Learn more about Naltrexone (oral) →

Choose Vivitrol (XR-naltrexone injection) if...

daily adherence is a challenge, you've relapsed on oral naltrexone, you want monthly dosing convenience, you're in early recovery needing structure, or court mandates monthly verification

Learn more about Vivitrol (XR-naltrexone injection) →

Still not sure which is right for you?

The level of care is a clinical decision based on addiction severity, withdrawal risk, and your home situation — not just personal preference. A free, confidential 2-minute self-assessment can help you gauge severity before you call, and our team can verify your insurance and match you to the right level of care at no cost.

Frequently asked questions

Is Vivitrol just monthly naltrexone?
Yes — Vivitrol is extended-release naltrexone (XR-naltrexone). The active medication is identical. What differs is the delivery system: oral tablets release medication immediately and clear within 1-2 days, while the Vivitrol injection releases medication slowly over 30 days. Same antagonist, different pharmacokinetics.
Why is Vivitrol so much more expensive?
Manufacturing the extended-release microsphere formulation is complex — it took Alkermes years to develop and FDA-approve. The patent and exclusive manufacturing keeps Vivitrol's price high ($1,500-$1,800 per dose uninsured) versus generic oral naltrexone ($30-$80/month). When Vivitrol's patent expires (estimated 2027-2028), generic versions may significantly reduce cost.
Can I switch from oral to Vivitrol or vice versa?
Yes, with medical supervision. Switching from oral to Vivitrol: take last oral dose, then any time after that get the injection (no waiting period since both are antagonists). Switching from Vivitrol to oral: wait until end of 30-day Vivitrol effect, then start oral. Many people use oral as bridge during the 7-10 day pre-induction abstinence period before first Vivitrol dose.
Why is the 7-10 day opioid abstinence required?
Naltrexone (in any form) is an opioid antagonist — it blocks opioid receptors. If you take naltrexone while opioids are still bound to receptors, the naltrexone displaces them and causes immediate severe withdrawal ("precipitated withdrawal"). Required wait: 7-10 days after short-acting opioids (heroin, fentanyl), 14+ days after long-acting (methadone). This induction barrier is the main practical limitation of naltrexone-based treatments.
Does naltrexone work for alcohol use disorder?
Yes — both oral naltrexone and Vivitrol are FDA-approved for alcohol use disorder. Mechanism: blocks the rewarding effects of alcohol consumption. For alcohol, naltrexone doesn't require pre-abstinence (alcohol doesn't bind to opioid receptors). Many people start naltrexone while still drinking and reduce gradually. Sometimes called "the Sinclair Method" for targeted alcohol use.
Is Vivitrol safer than buprenorphine or methadone?
Safety profile differs. Naltrexone (oral and Vivitrol) doesn't cause respiratory depression — overdose on the medication itself is extremely rare. But the protective effect requires adherence. If someone stops Vivitrol or oral naltrexone and relapses, they've lost tolerance during the abstinence period — putting them at very high overdose risk with the first use. This is why CDC and NIDA emphasize that buprenorphine and methadone have stronger overdose-mortality reduction evidence.
Can I drink alcohol on naltrexone?
Naltrexone is approved for alcohol use disorder, so the question is more nuanced than "yes/no." For people taking it FOR alcohol AUD: drinking won't produce the usual reward — the goal is reducing intoxication's pleasantness. For people taking it for OUD: occasional alcohol use is medically possible but not recommended due to liver-monitoring considerations. Discuss with your prescriber.
How long should I stay on naltrexone or Vivitrol?
No clinically mandated duration. Many people use it for 6-18 months during early recovery, then taper if stable. Others use it long-term as part of ongoing relapse prevention. Decision should involve a treating clinician. Unlike methadone or buprenorphine, naltrexone has no physical dependence — stopping doesn't cause withdrawal.
What about liver toxicity?
Both oral and Vivitrol carry FDA hepatotoxicity warnings. Baseline liver function tests (ALT, AST) are recommended before starting, with periodic monitoring (typically every 6 months). For most patients with normal liver function, naltrexone is safe. People with active hepatitis, severe liver disease, or alcohol-related liver dysfunction may need alternative MOUD options (buprenorphine, methadone) which don't have the same liver concerns.
Will Medicaid cover Vivitrol?
Yes — Medicaid covers Vivitrol in all 50 states as both OUD and AUD treatment per federal MOUD coverage requirements. Out-of-pocket typically $0-$50 per dose. Some Medicaid managed care plans may require step therapy (try oral naltrexone first), which can delay Vivitrol access by 30-60 days. If denied, appeal under MHPAEA federal parity rules.

Sources & references

Was this comparison helpful?
Share this comparison
X / Twitter Facebook LinkedIn

Need help deciding?

Free, confidential guidance from licensed advisors to help you choose between Naltrexone (oral) and Vivitrol (XR-naltrexone injection).

Last reviewed: May 12, 2026 • Sourced from SAMHSA, NIDA, peer-reviewed literature • Reviewed by RehabHive Editorial Team • Editorial policy